Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer

By Vizoso Francisco   Fernández José   Corte María   Bongera Miguel   Gava Richard   Allende María   García-Muñiz José   García-Morán Manuel  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 11, 2004-11 ,pp. : 679-686

Springer Publishing Company

Access to resources Recommend Favorite

CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer

By                    

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1570-1578

Spandidos Publications

Access to resources Recommend Favorite

CD44v6 promotes β-catenin and TGF-β expression, inducing aggression in ovarian cancer cells

By                    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3505-3510

Spandidos Publications

Access to resources Recommend Favorite

Rosiglitazone amplifies the sensitivity of docetaxel and reduces the expression of CD44v6

By        

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 1284-1288

Spandidos Publications

Access to resources Recommend Favorite

Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis

By Lackner C.  

Breast Cancer Research and Treatment, Vol. 47, Iss. 1, 1998-01 ,pp. : 29-40

Springer Publishing Company

Access to resources Recommend Favorite